Research Group on Molecular Microbiology and Microbial Pathogenesis

Oncology Area

Study of the basic aspects of infectious diseases

Study of the microorganisms that cause human pathology, characterization, biology and physiopathogenesis

The implementation and optimization of the use of new diagnostic technologies in the clinical management of infectious patients, particularly in the context of a basic onco-haematological pathology

Creation of multidisciplinary “diagnostic stewardship” Units (Programs for optimization of the use of diagnostic techniques -PRODIM-) with other services (Oncology/Hematology/ICU/Resuscitation, Primary Care)

Study of the immunobiology of patients with infectious diseases, characterization and study of their clinical impact on individuals and society

Dr. David Navarro Ortega
Coordinator
Dr. David Navarro Ortega
david.navarro@uv.es; navarrod@uv.es

RESEARCHERS
Leading, R4

David Navarro Ortega    

Established, R3

Jesús Rodríguez Díaz

Recognised/Emerging, R2

Estela Giménez Quiles    
Eliseo Alejandro Albert Vicent    
Enric Cuevas Ferrando
Ignacio Torres Fink    
Roberto Gozalbo Rovira

First Stage, R1

Ángela Sánchez Simarro
Cristina Santiso Bellón
José María Ferrer Chirivella
Nazaret Peña Gil
Roberto Cárcamo Calvo

STAFF
Collaborating Researchers

Javier Colomina Rodríguez
Mª Ángeles Clarí Pons
Sergi López Navarro

Nurse
Technicians

Ester Colomer Roig
Patricia Navarro Domínguez

Administrative assistant
Publications
Antibiotic susceptibility and genotypic characterization of Neisseria gonorrhoeae isolates in the Comunidad Valenciana (Spain): GONOvig project. Fabregat Bolufer AB, Bueno Ferrando F, Navarro Ortega D, Colomina Rodriguez J. Enfermedades Infecciosas y Microbiologia Clínica. 2024 Feb;42(2):69-73. doi: 10.1016/j.eimce.2022.08.009. PMID: 36646588

Emergence of cefiderocol resistance during ceftazidime/avibactam treatment caused by a large genomic deletion, including ampD and piuCD genes, in Pseudomonas aeruginosa. Gomis-Font M, Clari M, Lopez-Causapé C, Navarro D, Oliver A. Antimicrobial Agents and Chemotherapy. 2024 Jan 10;68(1):e0119223. doi: 10.1128/aac.01192-23. PMID: 38063398

A performance comparison of two (Electro) chemiluminescence immunoassays for detection and quantitation of serum anti-spike antibodies according to SARS-CoV-2 vaccination and infections status. Camacho J, Albert E, Zulaica J, Alvarez-Rodriguez B, Rusu L, Olea B, Alcaraz M, Geller R, Gimenez E, Navarro D. Journal of Medical Virology. 2023 Jan;95(1):e28397. doi: 10.1002/jmv.28397. PMID: 36504019

A rapid MALDI-TOF mass spectrometry-based method for categorization of Pseudomonas aeruginosa from blood cultures as susceptible or resistant to meropenem. Sanchez D, Torres I, Gimenez E, Albert E, Costa R, Padron C, Carretero D, Colomina J, Navarro D. Journal of Microbiological Methods. 2023 Aug 6;212:106803. doi: 10.1016/j.mimet.2023.106803. PMID: 37544430

American Society of Transplantation and Cellular Therapy Series: #7-Management of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplant Recipients. El Chaer F, Kaul D, Englund J, Boeckh M, Batista M, Seo S, Carpenter P, Navarro D, Hirsch H, Ison M, Papanicolaou G, Chemaly R. Transplantation and Cellular Therapy. 2023 Dec;29(12):730-738. doi: 10.1016/j.jtct.2023.09.018. PMID: 37783338

Assessment of the potential value of plasma Torque Teno virus DNA load monitoring to predict cytomegalovirus DNAemia in patients with hematological malignancies treated with small molecule inhibitors: a proof-of-concept study. de la Asunción C, Giménez E, Hernández-Boluda J, Terol M, Albert E, López J, García-Gutiérrez V, Andreu R, Malo M, Fox M, Remigia M, Amat P, Solano C, Navarro D. Journal of Medical Virology. 2023 Jul;95(7):e28933. doi: 10.1002/jmv.28933. PMID: 37403897

Culture of human rotaviruses in relevant models shows differences in culture-adapted and nonculture-adapted strains. Peña-Gil N, Randazzo W, Carmona-Vicente N, Santiso-Bellón C, Carcamo-Cálvo R, Navarro-Lleó N, Monedero V, Yebra M, Buesa J, Gozalbo-Rovira R, Rodríguez-Díaz J. International Journal of Molecular Sciences. 2023 Dec 11;24(24):17362. doi: 10.3390/ijms242417362. PMID: 38139191

Cumulative incidence of SARS-CoV-2 infection in the general population of the Valencian Community (Spain) after the surge of the Omicron BA.1 variant. Camacho J, Gimenez E, Albert E, Zulaica J, Alvarez-Rodriguez B, Torres I, Rusu L, Burgos J, Peiro S, Vanaclocha H, Limon R, Alcaraz M, Sanchez-Paya J, Diez-Domingo J, Comas I, Gonzales-Candelas F, Geller R, Navarro D. Journal of Medical Virology. 2023 Jan;95(1):e28284. doi: 10.1002/jmv.28284. PMID: 36333837

Cytomegalovirus DNAemia in hematological patients undergoing CD19-directed CAR-T cell therapy: should it be systematically monitored?. Solano de la Asuncion C, Hernani R, Albert E, Gomez M, Gimenez E, Benzaquen A, Gonzalez-Barbera E, Hernandez-Boluda J, Perez A, Pinana J, Chorao P, Guerreiro M, Montoro J, Sanz J, Solano C, Navarro D. Clinical Microbiology and Infection. 2023 Aug;29(8):1093-1095. doi: 10.1016/j.cmi.2023.05.010. PMID: 37182642

Dynamics and clinical significance of cytomegalovirus-specific neutralizing antibodies in kidney transplant recipients treated with T-Cell-depleting agents. Fernández-Ruiz M, Garcia-Ríos E, Redondo N, Rodríguez-Goncer I, Ruiz-Merlo T, Parra P, Sandonis V, López-Medrano F, San Juan R, González E, Polanco N, Andrés A, Navarro D, Aguado J, Pérez-Romero P. Journal of Infectious Diseases. 2023 Sep 22:jiad411. doi: 10.1093/infdis/jiad411. PMID: 37740549

Dynamics of Human Anelloviruses in plasma and clinical outcomes following kidney transplantation. Forque L, Fernandez-Ruiz M, Albert E, Gimenez E, Monzo C, Chaves J, Redondo N, Rodriguez-Goncer I, Ruiz-Merlo T, Parra P, Andres A, Aguado JM, Navarro D. Transplantation. 2023 Feb 1;107(2):511-520. doi: 10.1097/TP.0000000000004292. PMID: 36042550

Eikenella corrodens brain abscess after frontal sinusitis in immunocompetent patient. Salas Olortegui D, Moreno Felici O, Calvo Gomez J, Colomina Rodriguez J. Revista Espanola de Quimioterapia. 2023 Apr;36(2):211-213. doi: 10.37201/req/094.2022. PMID: 36648013

Evaluation of a quantitative dual-target EBV DNA test on a fully automated molecular testing system. Lutgehetmann M, Albert E, Hamilton A, Jarem D, Pfefferle S, Stucki H, Navarro D. Journal of Clinical Microbiology. 2023 Aug 23;61(8):e0051823. doi: 10.1128/jcm.00518-23. PMID: 37432105

Evaluation of a rapid turbidimetry-based method for the detection of cefotaxime-resistant Escherichia coli and Klebsiella spp. from blood cultures. Sanchez D, Colomina J, Navarro D, Torres I. Enfermedades Infecciosas y Microbiologia Clinica (English ed.). 2023 Aug-Sep;41(7):445-446. doi: 10.1016/j.eimce.2023.01.009. PMID: 37088685

Evaluation of the MDR direct flow chip kit for the detection of multiple antimicrobial resistance determinants. Rodriguez Villodres A, Galiana Cabrera A, Torres Fink I, Duran Jimenez R, Cisneros J, Lepe J. Microbial Drug Resistance. 2023 Aug;29(8):381-385. doi: 10.1089/mdr.2022.0264. PMID: 36961424

Features of cytomegalovirus DNAemia and virus-specific T-cell responses in allogeneic hematopoietic stem-cell transplant recipients during prophylaxis with letermovir. Gimenez E, Guerreiro M, Torres I, Aguilar C, Albert E, Hernandez-Boluda JC, Hernani R, Perez A, Amat P, Pinana JL, Montoro J, Solano C, Navarro D. Transplant Infectious Disease. 2023 Apr;25(2):e14021. doi: 10.1111/tid.14021. PMID: 36748748

Immunobiology of cytomegalovirus infection in patients with haematological malignancies undergoing treatment with small molecule inhibitors. Solano De la Asuncion C, Gimenez E, Hernandez-Boluda JC, Terol MJ, Albert E, Lopez-Jimenez J, Garcia-Gutierrez V, Andreu R, Garcia D, Fox ML, Remigia MJ, Amat P, Solano C, Navarro D. British Journal of Haematology. 2023 Mar;200(6):e58-e61. doi: 10.1111/bjh.18655. PMID: 36652997

Immunovirology of cytomegalovirus infection in allogeneic stem cell transplant recipients undergoing prophylaxis with letermovir: a narrative review. Solano C, Giménez E, Albert E, Piñana J, Navarro D. Journal of Medical Virology. 2023 Aug;95(8):e29005. doi: 10.1002/jmv.29005. PMID: 37526411

Impact of cytomegalovirus immunodominant HLA-I donor-recipient matching on the incidence and features of virus DNAemia and virus-specific T-cell immune reconstitution in unmanipulated haploidentical hematopoietic stem cell transplantation. Huntley D, Gimenez E, Vazquez L, Pascual M, Amat P, Remigia M, Hernandez-Boluda J, Garcia M, Gago B, Torres I, de la Asuncion C, Hernani R, Perez A, Albert E, Pinana J, Solano C, Navarro D. Transplant Infectious Disease. 2023 Jun;25(3):e14065. doi: 10.1111/tid.14065. PMID: 37120821

In vitro assessment of the combined effect of letermovir and sirolimus on cytomegalovirus replication. Gimenez E, Guerreiro M, Gozalbo-Rovira R, Aguilar C, Albert E, Pinana J, Solano C, Navarro D. Revista Espanola de Quimioterapia. 2023 Oct;36(5):526-530. doi: 10.37201/req/016.2023. PMID: 37365797

Incidence of refractory CMV infection with or without antiviral resistance in Spain: a systematic literature review. Aguado JM, Navarro D, Montoto C, Yébenes M, de Castro-Orós I. Transplantation Reviews. 2023 Nov 6:100804. doi: 10.1016/j.trre.2023.100804. PMID: 37949797

Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and lateral flow immunochromatography for rapid identification of beta-lactamase-gene-harboring Enterobacterales in urine specimens: Performance and cost-benefit analyses. Sánchez D, Torres I, Padrón C, Giménez E, Colomina J, Carretero D, Buesa J, Navarro D, Albert E. Diagnostic Microbiology and Infectious Disease. 2023 Oct 30;108(2):116127. doi: 10.1016/j.diagmicrobio.2023.116127. PMID: 37988931

Monitoring of plasma Torque teno virus, total Anelloviridae and Human Pegivirus 1 viral load for the prediction of infectious events and acute graft versus host disease in the allogeneic hematopoietic stem cell transplantation setting. Forqué L, Albert E, Piñana JL, Pérez A, Hernani R, Solano C, Navarro D, Giménez E. Journal of Medical Virology. 2023 Sep;95(9):e29107. doi: 10.1002/jmv.29107. PMID: 37721473

Multi-site performance evaluation of the Alinity m Molecular assay for quantifying Epstein-Barr virus DNA in plasma samples. Wessels E, Albert E, Vreeswijk T, Claas E, Gimenez E, Reinhardt B, Sasaki M, Navarro D. Journal of Clinical Microbiology. 2023 Oct 24;61(10):e0047223. doi: 10.1128/jcm.00472-23. PMID: 37728343

Multicenter performance evaluation of the Alinity m CMV assay for quantifying cytomegalovirus DNA in plasma samples. Lee M, Albert E, Wessels E, Kim S, Chung H, Gimenez E, Vreeswijk T, Claas E, Tai Y, Reinhardt B, Sasaki M, Navarro D. Journal of Clinical Microbiology. 2023 Oct 24;61(10):e0041523. doi: 10.1128/jcm.00415-23. PMID: 37728341

Multiplexable and biocomputational virus detection by CRISPR-Cas9-Mediated strand displacement. Marquez-Costa R, Montagud-Martinez R, Marques M, Albert E, Navarro D, Daros J, Ruiz R, Rodrigo G. Analytical Chemistry. 2023 Jun 27;95(25):9564-9574. doi: 10.1021/acs.analchem.3c01041. PMID: 37204239

Neutralizing antibodies against Omicron BA.4/5 after COVID-19 vaccination in SARS-CoV-2 experienced versus naive individuals in the general population. Camacho J, Zulaica J, Gimenez E, Rusu L, Velandia-Alvarez S, Albert E, Peiro S, Vanaclocha H, Limon R, Geller R, Navarro D. Journal of Infection. 2023 Mar;86(3):256-308. doi: 10.1016/j.jinf.2022.12.029. PMID: 36599404

One-year breakthrough SARS-CoV-2 infection and correlates of protection in fully vaccinated hematological patients. Pinana JL, Vazquez L, Calabuig M, Lopez-Corral L, Martin-Martin G, Villalon L, Sanz-Linares G, Conesa-Garcia V, Sanchez-Salinas A, Gago B, Facal A, Risco-Galvez I, Olave MT, Espigado I, Lopez-Jimenez J, Hernandez-Rivas JA, Avendano-Pita A, Arroyo I, Ferrer E, Garcia-Cadenas I, Gonzalez-Santillana C, Roldan-Perez A, Ferrer B, Guerreiro M, Suarez-Lledo M, Camara A, Campos-Beltran D, Navarro D, Cedillo A, Sureda A, Solano C, Martino R. Blood Cancer Journal. 2023 Jan 5;13(1):8. doi: 10.1038/s41408-022-00778-3. PMID: 36599843

Proposal for antimicrobial therapy stewardship of lower respiratory tract infection in mechanically-ventilated patients based upon the Biofire Filmarray Pneumonia Plus panel results. Clari M, Carbonell N, Albert E, Navarro D. Enfermedades Infecciosas y Microbiologia Clinica (English ed.). 2023 Oct;41(8):521-523. doi: 10.1016/j.eimce.2023.04.022. PMID: 37838453

Remdesivir or nirmatrelvir/ritonavir therapy for omicron SARS-CoV-2 infection in hematological patients and cell therapy recipients. Piñana J, Heras I, Aiello T, García-Cadenas I, Vazquez L, Lopez-Jimenez J, Chorao P, Aroca C, García-Vidal C, Arroyo I, Soler-Espejo E, López-Corral L, Avendaño-Pita A, Arrufat A, Garcia-Gutierrez V, Arellano E, Hernández-Medina L, González-Santillana C, Morell J, Hernández-Rivas J, Rodriguez-Galvez P, Mico-Cerdá M, Guerreiro M, Campos D, Navarro D, Cedillo A, Martino R, Solano C. Viruses. 2023 Oct 8;15(10):2066. doi: 10.3390/v15102066. PMID: 37896843

Respiratory virus infections after allogeneic stem cell transplantation: Current understanding, knowledge gaps, and recent advances. Pinana J, Perez A, Chorao P, Guerreiro M, Garcia-Cadenas I, Solano C, Martino R, Navarro D. Transplant Infectious Disease. 2023 Nov:25 Suppl 1:e14117. doi: 10.1111/tid.14117. PMID: 37585370

Role of the first WHO mutation catalogue in the diagnosis of antibiotic resistance in Mycobacterium tuberculosis in the Valencia Region, Spain: a retrospective genomic analysis. García-Marín AM, Cancino-Muñoz I, Torres-Puente M, Villamayor LM, Borrás R, Borrás-Máñez M, Bosque M, Camarena JJ, Colomer-Roig E, Colomina J, Escribano I, Esparcia-Rodríguez O, Gil-Brusola A, Gimeno C, Gimeno-Gascón A, Gomila-Sard B, González-Granda D, Gonzalo-Jiménez N, Guna-Serrano MR, López-Hontangas JL, Martín-González C, Moreno-Muñoz R, Navarro D, Navarro M, Orta N, Pérez E, Prat J, Rodríguez JC, Ruiz-García MM, Vanaclocha H, González-Candelas F, Furió V, Comas I. Lancet. Microbe. 2023 Dec 4:S2666-5247(23)00252-5. doi: 10.1016/S2666-5247(23)00252-5. PMID: 38061383

SARS-CoV-2 RNA loads in breakthrough COVID-19 caused by the Delta and Omicron variants. de Michelena P, Torres I, Ferrando E, Olea B, Gonzalez-Candelas F, Sanchez G, Navarro D. Clinical Microbiology and Infection. 2023 Feb;29(2):256.e1-256.e4. doi: 10.1016/j.cmi.2022.09.003. PMID: 36115649

SARS-CoV-2-reactive antibody waning, booster effect and breakthrough SARS-CoV-2 infection in hematopoietic stem cell transplant and cell therapy recipients at one year after vaccination. Pinana J, Martino R, Vazquez L, Lopez-Corral L, Perez A, Chorao P, Avendano Pita A, Pascual M, Sanchez Salinas A, Sanz Linares G, Olave M, Arroyo I, Tormo M, Villalon L, Conesa Garcia V, Gago B, Terol M, Villalba M, Garcia Gutierrez V, Cabero A, Hernandez Rivas J, Ferrer E, Garcia Cadenas I, Teruel A, Navarro D, Cedillo A, Sureda A, Solano C. Bone Marrow Transplantation. 2023 Feb 28;1-14. doi: 10.1038/s41409-023-01946-0. PMID: 36854892

Seroprevalence of antibodies against SARS-CoV-2 in the Valencian Community (Spain) as of October 2022. Garcia-Sempere A, Gimenez E, Vanaclocha H, Limon R, Peiro S, Navarro D. Gaceta Sanitaria. 2023 May 18;37:102312. doi: 10.1016/j.gaceta.2023.102312. PMID: 37331154

Standardizing In vitro & beta-lactam antibiotic allergy testing with synthetic IgE. Quintero-Campos P, Gozalbo-Rovira R, Rodriguez-Diaz J, Maquieira A, Morais S. Analytical Chemistry. 2023 Aug 15;95(32):12113-12121. doi: 10.1021/acs.analchem.3c02284. PMID: 37545056

The Biofire Filmarray Pneumonia Plus panel for management of lower respiratory tract infection in mechanically-ventilated patients in the COVID-19 era: a diagnostic and cost-benefit evaluation. Ferrer J, Clari M, Gimenez E, Carbonell N, Torres I, Blasco M, Albert E, Navarro D. Diagnostic Microbiology and Infectious Disease. 2023 Feb;105(2):115847. doi: 10.1016/j.diagmicrobio.2022.11584. PMID: 36403558

The CARBA-MAP study: national mapping of carbapenemases in Spain (2014-2018). Gracia-Ahufinger I, López-González L, Vasallo F, Galar A, Siller M, Pitart C, Bloise I, Torrecillas M, Gijón-Cordero D, Viñado B, Castillo-García J, Campo R, Mulet X, Madueño-Alonso A, Chamizo-López F, Arrastia-Erviti M, Galán-Sánchez F, Fernández-Quejo M, Rodríguez-Díaz J, Gutiérrez-Zufiaurre M, Rodríguez-Maresca M, Ortega-Lafont M, Yagüe-Guirao G, Chaves-Blanco L, Colomina-Rodríguez J, Vidal-Acuña M, Portillo M, de Luna F, Centelles-Serrano M, Azcona-Gutiérrez J, Campero A, Rey-Cao S, Muñoz P, Calvo-Montes J, Zboromyrska Y, Grandioso D, Càmara J, Cantón R, Larrosa-Escartín N, Díaz-Regañón J, Martinez-Martínez L. Frontiers in Microbiology. 2023 Sep 8:14:1247804. doi: 10.3389/fmicb.2023.1247804. PMID: 37744921

The role of the T-cell mediated immune response to Cytomegalovirus infection in intrauterine transmisión. Soriano-Ramos M, Esquivel-De la Fuente E, Vicent E, de la Calle M, Baquero-Artigao F, Dominguez-Rodriguez S, Cabanes M, Gomez-Montes E, Gonce A, Valdes-Bango M, Vinuela-Beneitez M, Gutierrez M, Saavedra-Lozano J, Perez I, Encinas B, Vilella L, Martfnez M, Tagarro A, Rodriguez-Molino P, Quiles E, Alcazar D, Burguillo A, Folgueira M, Navarro D, Blazquez-Gamero D. PLoS One. 2023 Feb 6;18(2):e0281341. doi: 10.1371/journal.pone.0281341. PMID: 36745589

Torque Teno Virus plasma DNA load: a novel prognostic biomarker in CAR-T therapy. Benzaquén A, Giménez E, Iacoboni G, Guerreiro M, Hernani R, Albert E, Carpio C, Balaguer A, Pérez A, S de la Asunción C, Sánchez-Salinas MA, Chorão P, Piñana JL, Beas F, Montoro J, Hernández-Boluda JC, Facal A, Ferrer B, Villalba M, Amat P, Goméz MD, Campos D, Terol MJ, Sanz J, Barba P, Navarro D, Solano C. Bone Marrow Transplantation. 2023 Nov 2. doi: 10.1038/s41409-023-02114-0. PMID: 37919456

Update of recommendations for the management of COVID-19 in patients with haematological malignancies, haematopoietic cell transplantation and CAR T therapy, from the 2022 European Conference on Infections in Leukaemia (ECIL 9). Cesaro S, Mikulska M, Hirsch H, Styczynski J, Meylan S, Cordonnier C, Navarro D, von Lilienfeld-Toal M, Mehra V, Marchesi F, Besson C, Masculano R, Beutel G, Einsele H, Maertens J, de la Camara R, Ljungman P, Pagano L. Leukemia. 2023 Sep;37(9):1933-1938. doi: 10.1038/s41375-023-01938-5. PMID: 37460673

An all-in-one point-of-care testing device for multiplexed detection of respiratory infections. Teixeira W, Pallas-Tamarit Y, Juste-Dolz A, Sena-Torralba A, Gozalbo-Rovira R, Rodriguez-Diaz J, Navarro D, Carrascosa J, Gimenez-Romero D, Maquieira A, Morais S. Biosensors & Bioelectronics. 2022 Jun 8;213:114454. doi: 10.1016/j.bios.2022.114454. PMID: 35696866

Applicability of probabilistic graphical models for early detection of SARS-CoV-2 reactive antibodies after SARS-CoV-2 vaccination in hematological patients. Pinana J, Rodriguez-Belenguer P, Caballero D, Martino R, Lopez-Corral L, Terol M, Vazquez L, Calabuig M, Sanz-Linares G, Marin-Jimenez F, Alonso C, Montoro J, Ferrer E, Facal A, Pascual M, Rodriguez-Fernandez A, Olave M, Cascales-Hernandez A, Gago B, Hernandez-Rivas J, Villalon L, Corona M, Roldan-Perez A, Ribes-Amoros J, Gonzalez-Santillana C, Garcia-Sanz R, Navarro D, Serrano-Lopez A, Cedillo A, Soria-Olivas E, Sureda A, Solano C. Annals of Hematology. 2022 Sep;101(9):2053-2067. doi: 10.1007/s00277-022-04906-8. PMID: 35780254

BD MAX enteric bacterial, bacterial plus, and virus panels for diagnosis of acute infectious gastroenteritis: a cost-benefit analysis. Ferrer J, Gimenez E, Carretero D, Buesa J, Morillas F, Granell R, Fuenmayor A, Navarro D, Albert E. Microbiology Spectrum. 2022 Oct 26;10(5):e0088022. doi: 10.1128/spectrum.00880-22. PMID: 36069590

Booster effect after SARS-CoV-2 vaccination in immunocompromised hematology patients with prior COVID-19. Piñana JL, Garcia-Sanz R, Martino R, Garcia-Roa M, Martin-Martin GA, Risco-Gálvez I, Tormo M, Martinez-Barranco P, Marcos-Corrales S, Calabuig M, Conesa V, Teruel A, Ruiz-Pérez S, Solano C, Navarro D, Cedillo Á, Sureda A. Blood Advances. 2022 Jan 8;6(3):848-853. doi: 10.1182/bloodadvances.2021006326. PMID: 34905620

CAPA in progress: a new real-life approach for the management of critically ill COVID-19 patients. Carbonell N, Alcaraz M, Serrano-Lazaro A, Rodriguez-Gimillo M, Ramos D, Ros F, Ferrer J, Blasco M, Navarro D, Clari M. Biomedicines. 2022 Jul 13;10(7):1683. doi: 10.3390/biomedicines10071683. PMID: 35884988

Cerebellious abscesses caused by Nocardia farcinica in an immunocompromised patient. Sanchez-Ramos D, Vega-Torres E, Irles-Vidal C, Colomina-Rodriguez J. Revista Espanola de Quimioterapia. 2022 Aug;35(4):418-420. doi: 10.37201/req/034.2022. PMID: 35711122

Combined kinetic analysis of SARS-CoV-2 RNAemia, N-antigenemia and virus-specific antibodies in critically ill adult COVID-19 patients. Costa R, Alberola J, Olea B, Gozalbo-Rovira R, Gimenez E, Cuevas-Ferrando E, Torres I, Albert E, Carbonell N, Ferreres J, Sanchez G, Rodriguez-Diaz J, Blasco M, Navarro D. Scientific Reports. 2022 May 18;12(1):8273. doi: 10.1038/s41598-022-12461-5. PMID: 35585163

Comparative evaluation of molecular methods for the quantitative measure of torquetenovirus viremia, the new surrogate marker of immune competence. Macera L, Spezia PG, Medici C, Rofi E, Del Re M, Focosi D, Mazzetti P, Navarro D, Antonelli G, Danesi R, Pistello M, Maggi F. Journal of Medical Virology. 2022 Feb;94(2):491-498. doi: 10.1002/jmv.25488. PMID: 31002743

Dynamics of SARS-CoV-2-Spike-reactive antibody and T-cell responses in chronic kidney disease patients within 3 months after COVID-19 full vaccination. Panizo N, Albert E, Gimenez-Civera E, Puchades M, D’Marco L, Gandia-Salmeron L, Gimenez E, Torre I, Sancho A, Gavela E, Gonzalez-Rico M, Montomoli M, Perez-Baylach C, Bonilla B, Solano C, Alvarado M, Torregrosa I, Alcaraz M, Gorriz J, Navarro D. Clinical Kidney Journal. 2022 Apr 9;15(8):1562-1573. doi: 10.1093/ckj/sfac093. PMID: 35880064

Evolution of SARS-CoV-2 immune responses in nursing home residents following full dose of the Comirnaty COVID-19 vaccine. Gimenez E, Alberola J, Torres I, Albert E, Alcaraz MJ, Botija P, Amat P, Remigia MJ, Beltran MJ, Rodado C, Huntley D, Olea B, Navarro D. Journal of Infection. 2022 Mar;84(3):418-467. doi: 10.1016/j.jinf.2021.10.026. PMID: 34740744

Human genetic polymorphisms and risk of viral infection after solid organ transplantation. Redondo N, Navarro D, Aguado JM, Fernandez-Ruiz M. Transplantation Reviews. 2022 Jan;36(1):100669. doi: 10.1016/j.trre.2021.100669. PMID: 34688126

Human pegivirus type 1 infection in kidney transplant recipients: replication kinetics and clinical correlates. Fernandez-Ruiz M, Forque L, Albert E, Redondo N, Gimenez E, Lopez-Medrano F, Gonzalez E, Polanco N, Ruiz-Merlo T, Parra P, San Juan R, Andres A, Aguado J, Navarro D. Transplant Infectious Disease. 2022 Feb;24(1):e13771. doi: 10.1111/tid.13771. PMID: 34921747

Immunological response against SARS-CoV-2 following full-dose administration of Comirnaty COVID-19 vaccine in nursing home residents. Albert E, Burgos JS, Peiro S, Salas D, Vanaclocha H, Gimenez E, Limon R, Alcaraz MJ, Sanchez-Paya J, Diez-Domingo J, Cervantes A, Navarro D. Clinical Microbiology and Infection. 2022 Feb;28(2):279-284. doi: 10.1016/j.cmi.2021.09.031. PMID: 34619398

Impact of polymorphisms in genes orchestrating innate immune responses on replication kinetics of Torque teno virus after kidney transplantation. Redondo N, Rodriguez-Goncer I, Parra P, Albert E, Gimenez E, Ruiz-Merlo T, Lopez-Medrano F, San Juan R, Gonzalez E, Sevillano A, Andres A, Navarro D, Aguado J, Fernandez-Ruiz M. Frontiers in Genetics. 2022 Nov 22;13:1069890. doi: 10.3389/fgene.2022.1069890. PMID: 36482892

Impact of time elapsed since full vaccination on SARS-CoV-2 RNA load in Delta-variant breakthrough COVID-19. De Michelena P, Torres I, Albert E, Bracho A, Gonzalez-Candelas F, Navarro D. Journal of Infection. 2022 Apr;84(4):579-613. doi: 10.1016/j.jinf.2022.01.006. PMID: 35016898

Initial SARS-CoV-2 RNA load in nasopharyngeal specimens is not associated with severity and midterm resolution of pneumonia in COVID-19 patients. Costa R, Signes-Costa J, Olea B, Tarraso J, Carbonell N, Blasco M, Navarro D. Journal of Infection. 2022 Dec;85(6):702-769. doi: 10.1016/j.jinf.2022.10.031. PMID: 36346264

Justification for 24/7 clinical microbiology services. Bou G, Calbo E, Crespo M, Canton R, de Luna F, Rodriguez J, Goenaga M, Gonzalez-Garcia J, Gonzalez J, Larrosa N, Martinez-Martinez L, Navarro D, Pano J, Rivero A, Rodriguez J, Tomas M, Vilaj J. Enfermedades Infecciosas y Microbiologia Clinica. 2022 Jan;40(1):1-4. doi: 10.1016/j.eimce.2021.08.014. PMID: 34991847

Methicillin-resistant Staphylococcus epidermidis infectious keratitis: clinical and microbiological profile. Vidal Oliver L, Bayo Calduch P, Forque Rodriguez L, Navarro Ortega D, Duch Samper AM, Colomina Rodriguez J. Revista Espanola de Quimioterapia. 2022 Apr;35(2):171-177. doi: 10.37201/req/128.2021. PMID: 35067009

Monitoring of Torque Teno virus DNAemia in critically ill COVID-19 patients: may it help to predict clinical outcomes?. Forque L, Albert E, Gimenez E, Torres I, Carbonell N, Ferreres J, Blasco M, Navarro D. Journal of Clinical Virology. 2022 Jan 23;148:105082. doi: 10.1016/j.jcv.2022.105082. PMID: 35091226

Multi-body-site colonization screening cultures for predicting multi-drug resistant Gram-negative and Gram-positive bacteremia in hematological patients. Torres I, Huntley D, Tormo M, Calabuig M, Hernandez-Boluda J, Terol M, Carretero C, de Michelena P, Perez A, Pinana J, Colomina J, Solano C, Navarro D. BMC Infectious Diseases. 2022 Feb 21;22(1):172. doi: 10.1186/s12879-022-07154-3. PMID: 35189833

Mycobacterial infections in adults with haematological malignancies and haematopoietic stem cell transplants: guidelines from the 8th European Conference on Infections in Leukaemia. Bergeron A, Mikulska M, De Greef J, Bondeelle L, Franquet T, Herrmann J, Lange C, Spriet I, Akova M, Donnelly J, Maertens J, Maschmeyer G, Rovira M, Goletti D, de la Camara R. Lancet Infectious Diseases. 2022 Dec;22(12):e359-e369. doi: 10.1016/S1473-3099(22)00227-4. PMID: 35636446

Neutralizing antibodies against SARS-CoV-2 variants of concern elicited by the comirnaty COVID-19 vaccine in nursing home residents. Sánchez-Sendra B, Albert E, Zulaica J, Torres I, Giménez E, Botija P, Beltrán MJ, Rodado C, Geller R, Navarro D. Scientific Reports. 2022 Mar 8;12(1):3788. doi: 10.1038/s41598-022-07849-2. PMID: 35260713

Performance comparison of a flow cytometry immunoassay for intracellular cytokine staining and the QuantiFERON SARS-CoV-2 test for detection and quantification of SARS-CoV-2-Spike-reactive-IFN-gamma-producing T cells after COVID-19 vaccination. Tormo N, Gimenez E, Martinez-Navarro M, Albert E, Navalpotro D, Torres I, Gimeno C, Navarro D. European Journal of Clinical Microbiology & Infectious Diseases. 2022 Apr;41(4):657-662. doi: 10.1007/s10096-022-04422-7. PMID: 35165804

Performance of a flow cytometry-based immunoassay for detection of antibodies binding to SARS-CoV-2 spike protein. Valdivia A, Tarin F, Alcaraz M, Pinero P, Torres I, Marco F, Albert E, Navarro D. Scientific Reports. 2022 Jan 12;12(1):586. doi: 10.1038/s41598-021-04565-1. PMID: 35022478

Population-based sequencing of Mycobacterium tuberculosis reveals how current population dynamics are shaped by past epidemics. Cancino-Munoz I, Lopez M, Torres-Puente M, Villamayor L, Borras R, Borras-Manez M, Bosque M, Camarena J, Colijn C, Colomer-Roig E, Colomina J, Escribano I, Esparcia-Rodriguez O, Garcia-Garcia F, Gil-Brusola A, Gimeno C, Gimeno-Gascon A, Gomila-Sard B, Gonzales-Granda D, Gonzalo-Jimenez N, Guna-Serrano M, Lopez-Hontangas J, Martin-Gonzalez C, Moreno-Munoz R, Navarro D, Navarro M, Orta N, Perez E, Prat J, Rodriguez J, Ruiz-Garcia M, Vanaclocha H, Comas I. eLife. 2022 Jul 26;11:e76605. doi: 10.7554/eLife.76605. PMID: 35880398

Real-life performance of a COVID-19 rapid antigen detection test targeting the SARS-CoV-2 nucleoprotein for diagnosis of COVID-19 due to the Omicron variant. de Michelena P, Torres I, Ramos Garcia A, Gozalbes V, Ruiz N, Sanmartin A, Botija P, Poujois S, Huntley D, Albert E, Navarro D. Journal of Infection. 2022 May;84(5):e64-e66. doi: 10.1016/j.jinf.2022.02.022. PMID: 35217106

RNA viral loads of SARS-CoV-2 Alpha and Delta variants in nasopharyngeal specimens at diagnosis stratified by age, clinical presentation and vaccination status. Costa R, Olea B, Bracho M, Albert E, de Michelena P, Martinez-Costa C, Gonzalez-Candelas F, Navarro D. Journal of Infection. 2022 Apr;84(4):579-613. doi: 10.1016/j.jinf.2021.12.018. PMID: 34953901

SARS-CoV-2 adaptive immunity in nursing home residents following a third dose of the Comirnaty COVID-19 vaccine. Gimenez E, Albert E, Zulaica J, Torres I, Rusu L, Rodriguez Moreno A, Burgos JS, Peiro S, Salas D, Vanaclocha H, Limon R, Alcaraz MJ, Sanchez-Paya J, Diez-Domingo J, Comas I, Gonzales Candelas F, Geller R, Navarro D. Clinical Infectious Diseases. 2022 Aug 24;75(1):e865-e868. doi: 10.1093/cid/ciac223. PMID: 35314856

SARS-CoV-2 adaptive immunity in nursing home residents up to eight months after two doses of the Comirnaty COVID-19 vaccine. Gimenez E, Albert E, Burgos JS, Peiro S, Salas D, Vanaclocha H, Limon R, Alcaraz MJ, Sanchez Paya J, Diez Domingo J, Comas I, Gonzales Candelas F. Journal of infection. 2022 Jun;84(6):834-872. doi: 10.1016/j.jinf.2022.02.035. PMID: 35245583

SARS-CoV-2 Delta-variant breakthrough infections in nursing home residents at midterm after Comirnaty (R) COVID-19 vaccination. Torres I, Bellido-Blasco JB, Gimeno C, Burgos JS, Albert E, Moya-Malo R, Gasco-Laborda JC, Tornero A, Soriano J, Meseguer-Ferrer N, Martinez-Serrano M, Ortiz-Rambla J, Buj H, Hernandez N, Peiro S, Salas D, Limon R, Vanaclocha H, Sanchez-Paya J, Diez-Domingo J, Comas I, Gonzalez-Candelas F, Navarro D. Journal of Medical Virology. 2022 Aug;94(8):3776-3782. doi: 10.1002/jmv.27799. PMID: 35445415

SARS-CoV-2 N-antigenemia in critically ill adult COVID-19 patients: frequency and association with inflammatory and tissue-damage biomarkers. Olea B, Albert E, Torres I, Gozalbo-Rovira R, Carbonell N, Ferreres J, Poujois S, Costa R, Colomina J, Rodriguez J, Blasco M, Navarro D. Journal of Medical Virology. 2022 Jan;94(1):222-228. doi: 10.1002/jmv.27300. PMID: 34449894

SARS-CoV-2 Omicron BA.1 variant breakthrough infections in nursing home residents after an homologous third dose of the Comirnaty (R) COVID-19 vaccine: looking for correlates of protection. Torres I, Gimenez E, Albert E, Zulaica J, Alvarez-Rodriguez B, Burgos J, Peiro S, Limon R, Vanaclocha H, Rodado C, Botija P, Sifre A, Tur B, Lozano R, Orosa I, Vicente-Ruiz M, Carrion R, Clari M, Sanchez-Paya J, Diez-Domingo J, Comas I, Gonzalez-Candelas F, Geller R, Navarro D. Journal of Medical Virology. 2022 Sep;94(9):4216-4223. doi: 10.1002/jmv.27867. PMID: 35585782

SARS-CoV-2 RNA load in nasopharyngeal specimens from outpatients with breakthrough COVID-19 due to Omicron BA.1 and BA.2. de Michelena P, Olea B, Torres I, Gonzalez-Candelas F, Navarro D. Journal of Medical Virology. 2022 Dec;94(12):5836-5840. doi: 10.1002/jmv.28079. PMID: 35986484

SARS-CoV-2 vaccine response and rate of breakthrough infection in patients with hematological disorders. Pinana JL, Lopez-Corral L, Martino R, Vazquez L, Perez A, Martin-Martin G, Gago B, Sanz-Linares G, Sanchez-Salinas A, Villalon L, Conesa-Garcia V, Olave MT, Corona M, Marcos-Corrales S, Tormo M, Hernandez-Rivas JA, Montoro J, Rodriguez-Fernandez A, Risco-Galvez I, Rodriguez-Belenguer P, Hernandez-Boluda JC, Garcia-Cadenas I, Ruiz-Garcia M, Munoz-Bellido JL, Solano C, Cedillo A, Sureda A, Navarro D. Journal of Hematology & Oncology. 2022 May 7;15(1):54. doi: 10.1186/s13045-022-01275-7. PMID: 35526045

SARS-CoV-2-reactive antibody detection after SARS-CoV-2 vaccination in hematopoietic stem cell transplant recipients: Prospective survey from the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH-TC). Pinana J, Lopez-Corral L, Martino R, Montoro J, Vazquez L, Perez A, Martin-Martin G, Facal-Malvar A, Ferrer E, Pascual M, Sanz-Linares G, Gago B, Sanchez-Salinas A, Villalon L, Conesa-Garcia V, Olave M, Lopez-Jimenez J, Marcos-Corrales S, Garcia-Blazquez M, Garcia-Gutierrez V, Hernandez-Rivas J, Saus A, Espigado I, Alonso C, Hernani R, Solano C, Ferrer-Lores B, Guerreiro M, Ruiz-Garcia M, Munoz-Bellido J, Navarro D, Cedillo A, Sureda A, Infectious Complications Subcommittee of the Spanish Hematopoietic Stem, Cell Transplantation and Cell Therapy Group (GETH-TC). American Journal of Hematology. 2022 Jan 1;97(1):30-42. doi: 10.1002/ajh.26385. PMID: 34695229

SARS-CoV-2-reactive IFN-gamma-producing CD4+ and CD8+ T cells in blood do not correlate with clinical severity in unvaccinated critically ill COVID-19 patients. Olea B, Albert E, Gimenez E, Torres I, Amat P, Remigia M, Alberola J, Carbonell N, Ferreres J, Blasco M, Navarro D. Scientific Reports. 2022 Aug 22;12(1):14271. doi: 10.1038/s41598-022-18659-x. PMID: 35995830

SARS-CoV-2-spike antibody and T-Cell responses elicited by a homologous third mRNA COVID-19 dose in hemodialysis and kidney transplant recipients. Panizo N, Gimenez E, Albert E, Zulaica J, Rodriguez-Moreno A, Rusu L, Gimenez-Civera E, Puchades M, D’Marco L, Gandia-Salmeron L, Torres I, Sancho A, Gavela E, Gonzalez-Rico M, Montomoli M, Perez-Baylach C, Bonilla B, Solano C, Alvarado M, Torregrosa I, Gonzales-Candia B, Alcaraz M, Geller R, Gorriz J, Navarro D. Microorganisms. 2022 Nov 16;10(11):2275. doi: 10.3390/microorganisms10112275. PMID: 36422345

Side effects during the week after first dose vaccination with four Covid-19 vaccines. Results of the ProVaVac Survey Study with 13,837 people in Spain. Sanchez-Saez F, Peiro S, Cuenca L, Vanaclocha H, Limon R, Salas D, Burgos JS, Sanchez-Paya J, Meneu R, Diez J, Garcia-Sempere A, Navarro I, Rodriguez-Bernal C, Sanfelix-Gimeno G, Navarro D. Vaccine. 2022 Sep 29;40(41):5942-5949. doi: 10.1016/j.vaccine.2022.08.028. PMID: 36068110

Spanish Society of Hematology and Hemotherapy expert consensus opinion for SARS-CoV-2 vaccination in onco-hematological patients. Pinana J, Vazquez L, Martino R, de la Camara R, Sureda A, Rodriguez-Veiga R, Garrido A, Sierra J, Ribera J, Torrent A, Mateos M, de la Rubia J, Tormo M, Diez-Campelo M, Garcia-Gutierrez V, Alvarez-Larran A, Sancho J, MartinGarcia-Sancho A, Yanez L, Simon J, Barba P, Abrisqueta P, Alvarez-Twose I, Bonanad S, Lecumberri R, Ruiz-Camps I, Navarro D, Hernandez-Rivas J, Cedillo A, Garcia-Sanz R, Bosch F. Leukemia & Lymphoma. 2022 Mar;63(3):538-550. doi: 10.1080/10428194.2021.1992619. PMID: 34668835

The effectiveness of mRNA vaccines to prevent SARS-CoV-2 infection and hospitalisation for COVID-19 according to the time elapsed since their administration in health professionals in the Valencian Autonomous Community (Spain). Chico-Sanchez P, Gras-Valenti P, Algado-Selles N, Jimenez-Sepulveda N, Vanaclocha H, Peiro S, Burgos J, Berenguer A, Navarro D, Sanchez-Paya J. Preventive Medicine. 2022 Oct;163:107237. doi: 10.1016/j.ypmed.2022.107237. PMID: 36057393

Viruses, friends, and foes: the case of Torque Teno Virus and the net state of immunosuppression. Redondo N, Navarro D, Aguado J, Fernandez-Ruiz M. Transplant Infectious Disease. 2022 Apr;24(2):e13778. doi: 10.1111/tid.13778. PMID: 34933413

Adaptive immune responses to SARS-CoV-2 in recovered severe COVID-19 patients. Olea B, Albert E, Torres I, Amat P, Remigia M, Gozalbo-Rovira R, Rodriguez-Diaz J, Buesa J, Blasco M, Redon J, Signes-Costa J, Navarro D. Journal of Clinical Virology. 2021 Sep;142:104943. doi: 10.1016/j.jcv.2021.104943. PMID: 34391981

Amplification of human beta-glucoronidase gene for appraising the accuracy of negative SARS-CoV-2 RT-PCR results in upper respiratory tract specimens. Albert Vicent E, Ferrer Lores B, Torres Fink I, Serrano Alcalá A, Alcaráz Soriana M, Buesa Gomez J, Solano Vercet C, Colomina Rodríguez F, Bueno Ferrando F, Huntley Pascual D, Olea Miguel B, Valdivia Piqueres A, Navarro Ortega D. Journal of Medical Virology. 2021 Jan;93(1):48-50. doi: 10.1002/jmv.26112. PMID: 32484950

Assessing the potential association between SARS-CoV-2 RNA load in the respiratory tract and COVID-19 mortality. Albert E, Bracho M, Serrano A, Ferrer B, Gonzalez-Candelas F, Navarro D. Journal of Medical Virology. 2021 Apr;93(4):1862-1864. doi: 10.1002/jmv.26644. PMID: 33135804

Bacterial metabolites trimethylamine N-oxide and butyrate as surrogates of small intestinal bacterial overgrowth in patients with a recent decompensated heart failure. Mollar A, Marrachelli V, Nunez E, Monleon D, Bodi V, Sanchis J, Navarro D, Nunez J. Scientific reports. 2021 Mar 17;11(1):6110. doi: 10.1038/s41598-021-85527-5. PMID: 33731747

Caveats in interpreting SARS-CoV-2 IgM positive/IgG negative antibody profile in asymptomatic health care workers.. Valdivia Piqueres A, Torres Fink I, Huntley Pascual D, Alcaráz Soriana M, Albert Vicent E, Solano De La Asunción C, González Padrón C, Ferrer Dot J, Navarro Ortega D. Journal of Medical Virology. 2021 Feb;93(2):634-636. doi: 10.1002/jmv.26400. PMID: 32761912

Clinical outcomes of allogeneic hematopoietic stem cell transplant recipients developing Cytomegalovirus DNAemia prior to engraftment. Solano C, Vazquez L, Gimenez E, de la Camara R, Albert E, Rovira M, Espigado I, Calvo C, Lopez-Jimenez J, Suarez-Lledo M, Chinea A, Esquirol A, Perez A, Bermudez A, Saldana R, Heras I, Gonzalez-Huerta A, Torrado T, Batlle M, Jimenez S, Vallejo C, Barba P, Cuesta M, Pinana J, Navarro D, Spanish Group of Hematopoietic Transplantation and Cell Therapy (GETH). Bone Marrow Transplantation. 2021 Jun;56(6):1281-1290. doi: 10.1038/s41409-020-01157-x. PMID: 33319853

Complicacion infecciosa poco frecuente tras autoinyecciones intramusculares. Sanchez Ramos D, Pinto Pla C, De Gracia Leon A, Colomina Rodriguez J. Revista Espanola de Quimioterapia. 2021 Aug;34(4):393-395. doi: 10.37201/req/024.2021. PMID: 34049434

COVID-19 infodemics: the role of mainstream and social media. Focosi D, Navarro D, Maggi F, Roilides E, Antonelli G. Clinical microbiology and infection. 2021 Nov;27(11):1568-1569. doi: 10.1016/j.cmi.2021.08.003. PMID: 34375756

Cytomegalovirus DNAemia and risk of mortality in allogeneic hematopoietic stem cell transplantation: Analysis from the Spanish Hematopoietic Transplantation and Cell Therapy Group. Solano Vercet C, Vazquez L, Gimenez Quiles E, De La Camara R, Albert Vicent E, Rovira M, Espigado I, Calvo C, Lopez-Jimenez J, Suarez-Lledo M, Chinea A, Esquirol A, Perez Martinez A, Bermudez A, Saldana R, Heras I, Gonzalez-Huerta A, Torrado T, Bautista G, Batlle M, Jimenez S, Vallejo C, Barba P, Cuesta M, Pinana J, Navarro Ortega D. American Journal of Transplantation. 2021 Jan;21(1):258-271. doi: 10.1111/ajt.16147. PMID: 32812351

Cytomegalovirus-specific T-cell immunity and DNAemia in patients with chronic lymphocytic leukaemia undergoing treatment with ibrutinib. De la Asuncion C, Terol M, Saus A, Olea B, Gimenez E, Albert E, Lopez-Jimenez J, Andreu R, Garcia D, Fox L, Remigia M, Amat P, Solano C, Navarro D. British Journal of Haematology. 2021 Nov;195(4):637-641. doi: 10.1111/bjh.17732. PMID: 34402042

Diagnostic significance of SARS-CoV-2 IgM positive/IgG negative antibody profile in symptomatic patients with suspected COVID-19 testing negative by RT-PCR. Valdivia Piqueres A, Torres Fink I, Huntley Pascual D, Alcaráz Soriana M, Albert Vicent E, González Padrón C, Colomina Rodríguez F, Navarro Ortega D. The Journal of infection. 2021 Jan;82(1):e15-e16. doi: 10.1016/j.jinf.2020.08.028. PMID: 32853600

Diversity and dynamic changes of Anelloviruses in plasma following Allogeneic Hematopoietic Stem Cell Transplantation. Gimenez Quiles E, Monzo Cataluña C, Albert Vicent E, Fuentes Trillo A, Seda García E, Pinana J, Hernandez Boluda J, Solano Vercet C, Chaves Martínez F, Navarro Ortega D. Journal of Medical Virology. 2021 Aug;93(8):5167-5172. doi: 10.1002/jmv.26661. PMID: 33174620

Early detection of SARS-CoV-2 infection cases or outbreaks at nursing homes by targeted wastewater tracking. Davo L, Segui R, Botija P, Beltran M, Albert E, Torres I, Lopez-Fernandez P, Orti R, Maestre J, Sanchez G, Navarro D. Clinical Microbiology and Infection. 2021 Jul;27(7):1061-1063. doi: 10.1016/j.cmi.2021.02.003. PMID: 33601008

Evaluation of a rapid antigen detection test (Panbio (TM) COVID-19 Ag Rapid Test Device) as a point-of-care diagnostic tool for COVID-19 in a pediatric emergency department. Carbonell-Sahuquillo S, Lazaro-Carreno M, Camacho J, Barres-Fernandez A, Albert E, Torres I, Breton-Martinez J, Martinez-Costa C, Navarro D. Journal of Medical Virology. 2021 Dec;93(12):6803-6807. doi: 10.1002/jmv.27220. PMID: 34289136

Evaluation of a rapid antigen test (Panbio COVID-19 Ag rapid test device) for SARS-CoV-2 detection in asymptomatic close contacts of COVID-19 patients. Torres I, Poujois S, Albert E, Colomina J, Navarro D. Clinical microbiology and infection. 2021 Apr;27(4):636.e1-636.e4. doi: 10.1016/j.cmi.2020.12.022. PMID: 33421573

Field evaluation of a rapid antigen test (Panbio™ COVID-19 Ag Rapid Test Device) for COVID-19 diagnosis in primary healthcare centers. Albert Vicent E, Torres Fink I, Bueno Ferrando F, Huntley Pascual D, Molla E, Fernandez-Fuentes M, Martínez López M, Poujois Gisbert S, Forqué Rodríguez L, Valdivia Piqueres A, Solano De La Asunción C, Ferrer Dot J, Colomina Rodríguez F, Navarro Ortega D. Clinical microbiology and infection. 2021 Mar;27(3):472.e7-472.e10. doi: 10.1016/j.cmi.2020.11.004. PMID: 33189872

Fundamentals and implementation of Microbiological Diagnostic Stewardship Programs. Bou G, Canton R, Martinez-Martinez L, Navarro Ortega D, Vila J. Enfermedades Infecciosas y Microbiologia Clinica. 2021 May;39(5):248-251. doi: 10.1016/j.eimc.2020.02.019. PMID: 32234252

Inference of SARS-CoV-2 spike-binding neutralizing antibody titers in sera from hospitalized COVID-19 patients by using commercial enzyme and chemiluminescent immunoassays. Valdivia A, Torres I, Latorre V, Frances-Gomez C, Albert E, Gozalbo-Rovira R, Alcaraz M, Buesa J, Rodriguez-Diaz J, Geller R, Navarro D. European Journal of Clinical Microbiology & Infectious Diseases. 2021 Mar;40(3):485-494. doi: 10.1007/s10096-020-04128-8. PMID: 33404891

Initial viral load and decay kinetics of SARS-CoV-2 lineage B.1.1.7 in the upper respiratory tract of adults and children. Costa R, Bueno F, Gimenez E, Bracho A, Albert E, Carretero D, de Michelena P, Martinez-Costa C, Gonzalez-Candelas F, Navarro D. Journal of Infection. 2021 Oct;83(4):496-522. doi: 10.1016/j.jinf.2021.08.015. PMID: 34390756

Lower respiratory tract and plasma SARS-CoV-2 RNA load in critically ill adult COVID-19 patients: Relationship with biomarkers of disease severity. Olea B, Albert E, Torres I, Gozalbo-Rovira R, Carbonell N, Ferreres J, Poujois S, Costa R, Colomina J, Rodriguez J, Blasco M, Navarro D. Journal of Infection. 2021 Sep;83(3):381-412. doi: 10.1016/j.jinf.2021.05.036. PMID: 34087349

Neisseria gonorrhoeae antimicrobial resistance in Spain: a prospective multicentre study. Salmeron P, Vinado B, Arando M, Alcoceba E, Romero B, Menendez B, Bernal S, Idigoras P, Colomina J, Martin-Saco G, Leal-Negredo A, Torreblanca A, Martinez O, Serra-Pladevall J. The Journal of Antimicrobial Chemotherapy. 2021 May 12;76(6):1523-1531. doi: 10.1093/jac/dkab037. PMID: 33569588

Performance of a MALDI-TOF mass spectrometry-based method for rapid detection of third-generation oxymino-cephalosporin-resistant Escherichia coli and Klebsiella spp. from blood cultures. Torres I, Albert E, Gimenez E, Olea B, Valdivia A, Pascual T, Huntley D, Sanchez D, Costa RM, Pinto C, Oltra R, Colomina J, Navarro D. European Journal of Clinical Microbiology & Infectious Diseases. 2021 Sep;40(9):1925-1932. doi: 10.1007/s10096-021-04251-0. PMID: 33876385

Qualitative assessment of SARS-CoV-2-specific antibody avidity by lateral flow immunochromatographic IgG/IgM antibody assay. Valdivia A, Torres I, Huntley D, Alcaraz M, Albert E, Colomina J, Ferrer J, Carratala A, Navarro D. Journal of Medical Virology. 2021 Feb;93(2):1141-1144. doi: 10.1002/jmv.26344. PMID: 32706420

Real-life evaluation of a rapid extraction-free SARS-CoV-2 RT-PCR assay (COVID-19 PCR Fast-L) for the diagnosis of COVID-19. Torres I, Qualai J, Albert E, Bueno F, Huntley D, Poujois S, Gil MT, Navarro D. Journal of Medical Virology. 2021 Sep;93(9):5233-5235. doi: 10.1002/jmv.27039. PMID: 33913561

SARS-CoV-2-reactive interferon-gamma-producing CD8+ T cells in patients hospitalized with Coronavirus Disease 2019. Gimenez Quiles E, Albert Vicent E, Torres Fink I, Remigia Pellicer M, Alcaráz Soriana M, Galindo Puerto M, Blasco Cortes M, Solano Vercet C, Forner Giner M, Redón Mas J, Signes-Costa Miñana J, Navarro Ortega D. Journal of Medical Virology. 2021 Jan;93(1):375-382. doi: 10.1002/jmv.26213. PMID: 32579268

SARS-CoV-2-specific cell-mediated immunity in kidney transplant recipients recovered from COVID-19. Fernandez-Ruiz M, Olea B, Gimenez E, Laguna-Goya R, Trujillo H, Caravaca-Fontan F, Gutierrez E, Lopez-Medrano F, Remigia M, Almendro-Vazquez P, Polanco N, Gonzalez E, Ruiz-Merlo T, Parra P, San Juan R, Andres A, Navarro D, Aguado J. Transplantation. 2021 Jun 1;105(6):1372-1380. doi: 10.1097/TP.0000000000003672. PMID: 33729741

Suitability of Two Rapid Lateral Flow Immunochromatographic Assays for Predicting SARS-CoV-2 Neutralizing Activity of Sera. Valdivia A, Torres I, Latorre V, Frances-Gomez C, Ferrer J, Forque L, Costa R, de la Asuncion C, Huntley D, Gozalbo-Rovira R, Buesa J, Gimenez E, Rodriguez-Diaz J, Geller R, Navarro D. Journal of Medical Virology. 2021 Apr;93(4):2301-2306. doi: 10.1002/jmv.26697. PMID: 33236799

The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant. Lopez M, Chiner-Oms A, Garcia de Viedma D, Ruiz-Rodriguez P, Bracho M, Cancino-Munoz I, D’Auria G, de Marco G, Garcia-Gonzalez N, Goig G, Gomez-Navarro I, Jimenez-Serrano S, Martinez-Priego L, Ruiz-Hueso P, Ruiz-Roldan L, Torres-Puente M, Alberola J, Albert Vicent E, Aranzamendi Zaldumbide M, Bea-Escudero M, Boga J, Bordoy A, Canut-Blasco A, Carvajal A, Cilla Eguiluz G, Cordon Rodriguez M, Costa-Alcalde J, de Toro M, de Toro Peinado I, Del Pozo J, Duchene S, Fernandez-Pinero J, Fuster Escriva B, Gimeno Cardona C, Gonzalez Galan V, Gonzalo Jimenez N, Hernaez Crespo S, Herranz M, Lepe J, Lopez-Causape C, Lopez-Hontangas J, Martin V, Martro E, Milagro Beamonte A, Montes Ros M, Moreno-Munoz R, Navarro Ortega D, Navarro-Mari J, Not A, Oliver A, Palop-Borras B, Parra Grande M, Pedrosa-Corral I, Perez Gonzalez M, Perez-Lago L, Perez-Ruiz M, Pineiro Vazquez L, Rabella N, Rezusta A, Robles Fonseca L, Rodriguez-Villodres A, Sanbonmatsu-Gamez S, Sicilia J, Soriano A, Tirado Balaguer M, Torres Fink I, Tristancho A, Marimon J, Coscolla M, Gonzalez-Candelas F, Comas I, SeqCOVID-Spain consortium. Nature Genetics. 2021 Oct;53(10):1405-1414. doi: 10.1038/s41588-021-00936-6. PMID: 34594042

Upper respiratory tract SARS-CoV-2 RNA loads in symptomatic and asymptomatic children and adults. Costa R, Bueno F, Albert E, Torres I, Carbonell-Sahuquillo S, Barres-Fernandez A, Sanchez D, Padron C, Colomina J, Lazaro Carreno M, Breton-Martinez J, Martinez-Costa C, Navarro D. Clinical Microbiology and Infection. 2021 Dec;27(12):1858.e1-1858.e7. doi: 10.1016/j.cmi.2021.08.001. PMID: 34384874

Projects
Reference: AICO/2021/033
Title: Role of host mucosal glycosylation in SARS-CoV-2 infectivity 
Funding body: Conselleria de Innovación, Universidades, Ciencia y Sociedad Digital
Principal Investigator: Jesús Rodríguez Díaz
Duration: 2022 – 2024
Total budget: 90.000 €
Reference: PI21/00563
Title: Inmunidad adaptativa de linfocitos B y T frente a SARS-CoV-2 tras la vacunación de pacientes en riesgo de sufrir COVID-19 severa
Funding body: Instituto de Salud Carlos III – Cofinanciado FEDER
Principal Investigator: David Navarro Ortega, Estela Giménez
Duration: 2022 – 2024
Total budget: 169.400 €
Reference: 896932-TTVGuideTX
Title: Personalisation of immunosuppression by monitoring viral load post kidney transplantation – a randomised controlled phase II trial
Funding body: European Commission
Principal Investigator: David Navarro Ortega
Duration: 2021 – 2026
Total budget: 85.625 €
Reference: PID2020-115403RB-C22
Title: Glicosil hidrolasas bacterianas y su función en la infectividad viral
Funding body: Ministerio de Ciencia e Innovación
Principal Investigator: Jesús Rodríguez Díaz
Duration: 2021 – 2024
Total budget: 160.930 €
Reference: PI-2021-004
Title: TECO: Validación de dos sistemas biosensor para la diagnosis simultánea de covid19 y otros patógenos aéreos
Funding body: Universidad de Valencia – INCLIVA
Principal Investigator: David Giménez Romero, Estela Giménez Quiles
Duration: 2021 – 2022
Total budget: 19.000 €
Reference: PI18/00127
Title: Virología e inmunología de la infección por el citomegalovirus (CMV) en el paciente con neoplasia hematológicas en la era de las nuevas bioterapias
Funding body: Instituto de Salud Carlos III – Cofinanciado FEDER
Principal Investigator: David Navarro Ortega
Duration: 2019 – 2022
Total budget: 111.320 €
Reference: PI15/00090
Title: Inmunobiología de la infección por el citomegalovirus en el trasplante alogénico de precursores hematopoyéticos haploidéntico asociado al uso de ciclofosfamida postrasplante
Funding body: Instituto de Salud Carlos III – Cofinanciado FEDER
Principal Investigator: David Navarro Ortega
Duration: 2016 – 2019
Total budget: 98.615 €
+ Info
Mycobacterial infections in adults with haematological malignancies and haematopoietic stem cell transplants: guidelines from the 8th European Conference on Infections in Leukaemia. Bergeron A, Mikulska M, De Greef J, Bondeelle L, Franquet T, Herrmann J, Lange C, Spriet I, Akova M, Donnelly J, Maertens J, Maschmeyer G, Rovira M, Goletti D, de la Camara R. Lancet Infectious Diseases. 2022 Dec;22(12):e359-e369. doi: 10.1016/S1473-3099(22)00227-4. PMID: 35636446

Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European Conference on Infections in Leukaemia (ECIL 7). Ljungman P, de la Camara R, Robin C, Crocchiolo R, Einsele H, Hill JA6, Hubacek P7, Navarro D8, Cordonnier C3, Ward KN9; 2017 European Conference on Infections in Leukaemia group. LANCET INFECTIOUS DISEASES. 2019 Aug; 19(8): e260-e272. doi: 10.1016/S1473-3099(19)30107-0. PMID: 31153807

Title: Nuevas aplicaciones del Sistema MALDI-TOF MS en la microbiología clínica
Doctoral candidate: Torres Fink, Ignacio
Director(s): Navarro Ortega, David
Date of the defense: 14/07/2022
University: Universitat de València

Title: Valor predictivo de la carga viral de citomegalovirus y torquetenovirus en heces y plasma del desarrollo de la enfermedad injerto contra huésped intestinal en pacientes sometidos a trasplante alogénico de precursores hematopoyéticos
Doctoral candidate: Bueno Ferrando, Felipe
Director(s): Navarro Ortega, David
Date of the defense: 15/06/2022
University: Universitat de València

Title: Factores predictivos de desarrollo y evolución de infección activa por citomegalovirus en el trasplante alogénico de precursores hematopoyéticos
Doctoral candidate: Vinuesa Velasco, Víctor
Director(s): Navarro Ortega, David
Date of the defense: 08/09/2021
University: Universitat de València

Title: Parámetros biológicos predictivos de la infección activa precoz por Citomegalovirus en el trasplante alogénico de precursores hematopoyéticos
Doctoral candidate: Talaya Peñalver, Alberto
Director(s): Navarro Ortega, David
Date of the defense: 26/05/2021
University: Universitat de València

Title: Desarrollo de un dispositivo médico tipo “point of care” para la detección rápida de infección urinaria y sensibilidad antibiótica en países en vías de desarrollo
Doctoral candidate: Jover García, Jorge
Director(s): Colomina Rodríguez, Javier
Date of the defense: 12/03/2021
University: Universitat de València

Title: Vigilancia de la susceptibilidad antibiótica y caracterización genotípica de aislados de Neisseria Gonorrhoeae en la Comunidad Valenciana: proyecto multicéntrico GONOvig
Doctoral candidate: Fabregat Bolufer, Aleix Borja
Director(s): Colomina Rodríguez, Javier
Date of the defense: 26/02/2021
University: Universitat de València

Title: Torque teno virus como marcador subrogado de inmunocompetencia en el trasplante
Doctoral candidate: Albert Vicent, Eliseo
Director(s): Navarro Ortega, David
Date of the defense: 13/02/2020
University: Universitat de València

Title: Concentración mínima inhibitoria de vancomicina para staphylococcus aureus y riesgo de bacteriemia complicada
Doctoral candidate: Falcón Abad, Rocío
Director(s): Navarro Ortega, David
Date of the defense: 02/10/2019
University: Universitat de València